Female Reproductive System Endometrioid Adenocarcinoma

Female Reproductive System Endometrioid Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

111 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 20
Ph III recruiting: 6
Growth YoY: —
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05403554	A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers	recruiting	Phase 1	70	Light Chain Bioscience - Novimmune SAINDUSTRY	2	Oct 29, 2024	clinicaltrials
NCT01686126	Improving the Treatment for Women With Early Stage Cancer of the Uterus(feMMe)	active not recruiting	Phase 2	165	Queensland Centre for Gynaecological CancerOTHER_GOV	2	Aug 28, 2024